Your browser doesn't support javascript.
loading
Rare co-occurrence of multiple sclerosis and Wilson's disease - case report.
Despotov, Katalin; Klivényi, Péter; Nagy, István; Pálvölgyi, Attila; Vécsei, László; Rajda, Cecília.
Afiliação
  • Despotov K; Department of Neurology, University of Szeged, Faculty of Medicine, Szeged, Hungary.
  • Klivényi P; Department of Neurology, University of Szeged, Faculty of Medicine, Szeged, Hungary.
  • Nagy I; Faculty of Medicine, Department of Internal Medicine I, University of Szeged, Szeged, Hungary.
  • Pálvölgyi A; Faculty of Medicine, Department of Internal Medicine I, University of Szeged, Szeged, Hungary.
  • Vécsei L; Department of Neurology, University of Szeged, Faculty of Medicine, Szeged, Hungary.
  • Rajda C; MTA-SZTE Neuroscience Research Group, Szeged, Hungary.
BMC Neurol ; 22(1): 178, 2022 May 16.
Article em En | MEDLINE | ID: mdl-35578211
ABSTRACT

BACKGROUND:

Wilson's disease is a hereditary disorder of copper metabolism resulting mainly in hepatic, neurological, and psychiatric symptoms. Multiple sclerosis (MS) is an immune-mediated demyelinating disease affecting the central nervous system (CNS). The co-occurrence of these two, although not unheard of in literature, is still considered to be very rare and can give rise to diagnostic difficulties. Also, comorbidity in MS highly influences quality of life and disease progression, which makes the timely diagnosis and treatment of these conditions essential. CASE PRESENTATION The aim of this study is to present a patient exhibiting symptoms of both MS and Wilson's disease, as well as to conduct a detailed review of previously reported cases. The patient's neurological symptoms (sensory disorder) as well as MRI and CSF findings were characteristic for MS. The diagnosis of MS preceded that of Wilson's disease and was relatively mild in course. Currently, the patient receives cladribine as an immunomodulatory treatment after escalation from glatiramer acetate therapy. Apart from one episode of acute hepatic decompensation, during which transfusion, albumin supplementation and diuretic treatment was necessary, Wilson's disease manifested as chronic impairment of liver function. The diagnosis of Wilson's disease was established by the analysis of serum coeruloplasmin levels, histological examination and genetic findings. Continuous oral penicillamine therapy led to the slow normalization of hepatic function and significant amelioration of the patient's symptoms. Correlating with cases previously reported, the course of MS was relatively mild, and like in three out of four other known cases, the symptoms of Wilson's disease were mostly restricted to hepatic dysfunction.

CONCLUSION:

The case presented in our report is similar to those reported before. The co-occurrence of the two diseases seems to be more a coincidence than a sharing of common factors in their pathogenesis; however, they are considered to influence one another. Regarding rare co-occurrences such as this one, every new case is of high importance, as it enables a better evaluation and understanding of the clinical presentations that are more characteristic of these cases, thus aiding the estimation of disease course as well as possible therapeutic choices.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Degeneração Hepatolenticular / Esclerose Múltipla Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Degeneração Hepatolenticular / Esclerose Múltipla Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article